Inogen Inc (INGN) 33.53 $INGN
Varian Medical's ProBeam Proton Therapy Now in Denmark - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 2:43PM CST
In addition to the ProBeam system, Varian Medical Systems Inc. (VAR) will provide the Denmark center with its ARIA information management software.
ABMD: 60.39 (+0.46), VAR: 92.65 (+0.03), INGN: 33.53 (+2.32), LMNX: 15.45 (+0.02)
Allscripts Sunrise EHR: IHMC's Choice for Flagship Hospital - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 1:57PM CST
Allscripts recently announced that its Sunrise Acute Care has been selected by Texas-based International Hospital Management Corp. (IHMC).
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), MDRX: 11.80 (+0.04), SURG: 4.44 (-0.02)
Bioanalytical Systems' Breakeven Q1 Earnings, Down Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 9:00AM CST
Bioanalytical Systems (BASI) reported adjusted breakeven earnings per share (EPS) in the first quarter of fiscal 2015, which was lower by 3 cents on a year-over-year basis
ABMD: 60.39 (+0.46), BASI: 2.06 (+0.18), INGN: 33.53 (+2.32), SURG: 4.44 (-0.02)
Alere (ALR) Disappoints; Misses on Earnings, Revenues in Q4 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 8:44AM CST
Alere Inc. (ALR) reported disappointing fourth-quarter 2014 results with both its top and bottom line missing the Zacks Consensus Estimate.
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), ALR: 43.40 (-0.40), SURG: 4.44 (-0.02)
Cepheid Strong on Q4, Global Expansion; Currency Woes Stay - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 1:09PM CST
Cepheid (CPHD) reported adjusted breakeven earnings per share in the quarter, which compared favorably with the Zacks Consensus Estimate of a loss of 14 cents.
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), CPHD: 59.62 (+0.72), LMNX: 15.45 (+0.02)
Acadia Healthcare Posts In-Line Q4 Earnings, Revenue Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 8:54AM CST
Acadia Healthcare Company (ACHC) reported fourth-quarter 2014 adjusted earnings (EPS) of 46 cents per share, which surged an impressive 58.6% year over year.
ACHC: 63.20 (-0.45), ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), SURG: 4.44 (-0.02)
Thoratec Beats Q4 Earnings and Revenues, Shares Rise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 8:45AM CST
Shares of Thoratec Corp. (THOR) rallied 4.37% ($1.59) to $38.00 after the company reported impressive fourth-quarter financial numbers.
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), THOR: 40.01 (+0.54), LMNX: 15.45 (+0.02)
Fluidigm Q4 Loss Narrower Than Expected, Revenues Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 8:10AM CST
Following the earnings announcement on Feb 5, shares of Fluidigm Corp (FLDM) rallied nearly 2.8% to open at $39.85 on Friday.
ABMD: 60.39 (+0.46), FLDM: 37.93 (-0.47), INGN: 33.53 (+2.32), LMNX: 15.45 (+0.02)
Accuray's TomoTherapy Gains Traction in Latin America (Revised) - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 8:00AM CST
Accuray Inc's (ARAY) TomoTherapy System recently started operating breast cancer patients at Fundacion de Cancer de Mama (FUCAM) in Mexico City
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), ARAY: 8.00 (+0.24), LMNX: 15.45 (+0.02)
Invacare (IVC) Reports Narrower Q4 Loss, Beats on Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 8:29AM CST
Invacare Corp. (IVC) reported adjusted loss of 12 cents per share in the fourth quarter of 2014, which was narrower than the Zacks Consensus Estimate of a loss of 23 cents
ABMD: 60.39 (+0.46), IVC: 17.13 (+0.15), INGN: 33.53 (+2.32), SURG: 4.44 (-0.02)
Mettler-Toledo Tops Earnings, Revenues on Margin Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 8:16AM CST
Mettler-Toledo International Inc. (MTD) reported an impressive fourth-quarter 2014 wherein adjusted EPS of $4.24 beat the Zacks Consensus Estimate by 9 cents
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), LMNX: 15.45 (+0.02), MTD: 307.00 (-0.13)
Accuray's TomoTherapy Gains Traction in Latin America - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 05, 5:25PM CST
Accuray Inc's (ARAY) TomoTherapy System recently started operating breast cancer patients at Fundacion de Cancer de Mama (FUCAM) in Mexico City.
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), LMNX: 15.45 (+0.02), ARAY: 8.00 (+0.24)
Affymetrix (AFFX) Earnings, Revenues Outshine Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 05, 8:56AM CST
Affymetrix Inc. (AFFX) reported adjusted earnings per share (EPS) of 9 cents in the fourth quarter of 2014, which managed to beat the Zacks Consensus Estimate by a couple of cents
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), AFFX: 11.45 (+0.02), SURG: 4.44 (-0.02)
Luminex (LMNX): Strong Buy on Solid Q4 & Pipeline Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 04, 6:32PM CST
On Feb 4, 2015, Zacks Investment Research raised Luminex Corp (LMNX) to a Zacks Rank #1 (Strong Buy).
ABMD: 60.39 (+0.46), TMO: 127.61 (+0.78), INGN: 33.53 (+2.32), LMNX: 15.45 (+0.02)
Edwards Lifesciences Tops Q4 Earnings, Sales; Alters View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 04, 9:10AM CST
Edwards Lifesciences (EW) reported sales of $618 million, up 15.3% year over year. The top line also outshone the Zacks Consensus Estimate of $609 million.
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), EW: 134.23 (+1.89), LMNX: 15.45 (+0.02)
Techne Q2 Earnings, Revenues Miss Estimates but Grow Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 04, 8:56AM CST
Techne Corp. (TECH) reported adjusted earnings (EPS) of 82 cents per share in the second quarter of fiscal 2015, which missed the Zacks Consensus Estimate by 4 cents
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), TECH: 94.61 (+1.83), SURG: 4.44 (-0.02)
Pacific Biosciences Posts Q4 Loss as Expected, Shares Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 04, 8:28AM CST
Pacific Biosciences of California Inc. (PACB) plunged 5.2% (43 cents) to $7.90 in after-hours trading on the heels of disappointing fourth-quarter results.
ABMD: 60.39 (+0.46), PACB: 6.96 (-0.06), INGN: 33.53 (+2.32), SURG: 4.44 (-0.02)
InsiderInsights.com Daily Round Up 2/3/15: HES, FANG, ARDX, BH
InsiderInsights - at Seeking Alpha - Wed Feb 04, 5:43AM CST
NLSN: 45.59 (+2.02), HES: 76.83 (+2.12), CUBI: 22.29 (-0.14), FB: 75.74 (-0.49), LLY: 70.56 (+0.03), BMY: 60.04 (+0.56), ARDX: 17.14 (+0.71), ARCI: 2.53 (-0.01), BH: 416.41 (-1.55), WIW: 11.29 (unch), MJN: 101.89 (+2.32), SCTY: 57.60 (+0.44), ARRS: 26.68 (+0.41), GDOT: 15.54 (+0.34), INGN: 33.53 (+2.32), EMC: 27.99 (+0.12), FANG: 73.46 (+0.49), MSFT: 43.87 (+0.78), LENS: 6.00 (-0.67), BLMN: 24.45 (-0.16)
Intuitive Surgical Announces $1B Share Buyback Program - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 03, 4:57PM CST
Intuitive Surgical Inc (ISRG) recently announced a new share buyback program worth $1 billion.
ISRG: 510.73 (+3.02), ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), SURG: 4.44 (-0.02)
Wright Medical (WMGI) Gets Second Request from FTC - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 03, 3:20PM CST
Wright Medical Group, Inc. (WMGI) recently announced that it has received a Request for Additional Information and Documentary Material (commonly known as a Second Request) from the Federal Trade Commission ("FTC"
.
WMGI: 25.68 (+0.17), INGN: 33.53 (+2.32), TRNX: 25.32 (+0.12), SURG: 4.44 (-0.02)
Varian Medical's ProBeam Proton Therapy Now in Denmark - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 2:43PM CST
In addition to the ProBeam system, Varian Medical Systems Inc. (VAR) will provide the Denmark center with its ARIA information management software.
ABMD: 60.39 (+0.46), VAR: 92.65 (+0.03), INGN: 33.53 (+2.32), LMNX: 15.45 (+0.02)
Allscripts Sunrise EHR: IHMC's Choice for Flagship Hospital - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 1:57PM CST
Allscripts recently announced that its Sunrise Acute Care has been selected by Texas-based International Hospital Management Corp. (IHMC).
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), MDRX: 11.80 (+0.04), SURG: 4.44 (-0.02)
Bioanalytical Systems' Breakeven Q1 Earnings, Down Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 9:00AM CST
Bioanalytical Systems (BASI) reported adjusted breakeven earnings per share (EPS) in the first quarter of fiscal 2015, which was lower by 3 cents on a year-over-year basis
ABMD: 60.39 (+0.46), BASI: 2.06 (+0.18), INGN: 33.53 (+2.32), SURG: 4.44 (-0.02)
Alere (ALR) Disappoints; Misses on Earnings, Revenues in Q4 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 8:44AM CST
Alere Inc. (ALR) reported disappointing fourth-quarter 2014 results with both its top and bottom line missing the Zacks Consensus Estimate.
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), ALR: 43.40 (-0.40), SURG: 4.44 (-0.02)
Cepheid Strong on Q4, Global Expansion; Currency Woes Stay - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 1:09PM CST
Cepheid (CPHD) reported adjusted breakeven earnings per share in the quarter, which compared favorably with the Zacks Consensus Estimate of a loss of 14 cents.
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), CPHD: 59.62 (+0.72), LMNX: 15.45 (+0.02)
Acadia Healthcare Posts In-Line Q4 Earnings, Revenue Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 8:54AM CST
Acadia Healthcare Company (ACHC) reported fourth-quarter 2014 adjusted earnings (EPS) of 46 cents per share, which surged an impressive 58.6% year over year.
ACHC: 63.20 (-0.45), ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), SURG: 4.44 (-0.02)
Thoratec Beats Q4 Earnings and Revenues, Shares Rise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 8:45AM CST
Shares of Thoratec Corp. (THOR) rallied 4.37% ($1.59) to $38.00 after the company reported impressive fourth-quarter financial numbers.
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), THOR: 40.01 (+0.54), LMNX: 15.45 (+0.02)
Fluidigm Q4 Loss Narrower Than Expected, Revenues Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 8:10AM CST
Following the earnings announcement on Feb 5, shares of Fluidigm Corp (FLDM) rallied nearly 2.8% to open at $39.85 on Friday.
ABMD: 60.39 (+0.46), FLDM: 37.93 (-0.47), INGN: 33.53 (+2.32), LMNX: 15.45 (+0.02)
Accuray's TomoTherapy Gains Traction in Latin America (Revised) - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 8:00AM CST
Accuray Inc's (ARAY) TomoTherapy System recently started operating breast cancer patients at Fundacion de Cancer de Mama (FUCAM) in Mexico City
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), ARAY: 8.00 (+0.24), LMNX: 15.45 (+0.02)
Invacare (IVC) Reports Narrower Q4 Loss, Beats on Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 8:29AM CST
Invacare Corp. (IVC) reported adjusted loss of 12 cents per share in the fourth quarter of 2014, which was narrower than the Zacks Consensus Estimate of a loss of 23 cents
ABMD: 60.39 (+0.46), IVC: 17.13 (+0.15), INGN: 33.53 (+2.32), SURG: 4.44 (-0.02)
Mettler-Toledo Tops Earnings, Revenues on Margin Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 8:16AM CST
Mettler-Toledo International Inc. (MTD) reported an impressive fourth-quarter 2014 wherein adjusted EPS of $4.24 beat the Zacks Consensus Estimate by 9 cents
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), LMNX: 15.45 (+0.02), MTD: 307.00 (-0.13)
Accuray's TomoTherapy Gains Traction in Latin America - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 05, 5:25PM CST
Accuray Inc's (ARAY) TomoTherapy System recently started operating breast cancer patients at Fundacion de Cancer de Mama (FUCAM) in Mexico City.
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), LMNX: 15.45 (+0.02), ARAY: 8.00 (+0.24)
Affymetrix (AFFX) Earnings, Revenues Outshine Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 05, 8:56AM CST
Affymetrix Inc. (AFFX) reported adjusted earnings per share (EPS) of 9 cents in the fourth quarter of 2014, which managed to beat the Zacks Consensus Estimate by a couple of cents
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), AFFX: 11.45 (+0.02), SURG: 4.44 (-0.02)
Luminex (LMNX): Strong Buy on Solid Q4 & Pipeline Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 04, 6:32PM CST
On Feb 4, 2015, Zacks Investment Research raised Luminex Corp (LMNX) to a Zacks Rank #1 (Strong Buy).
ABMD: 60.39 (+0.46), TMO: 127.61 (+0.78), INGN: 33.53 (+2.32), LMNX: 15.45 (+0.02)
Edwards Lifesciences Tops Q4 Earnings, Sales; Alters View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 04, 9:10AM CST
Edwards Lifesciences (EW) reported sales of $618 million, up 15.3% year over year. The top line also outshone the Zacks Consensus Estimate of $609 million.
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), EW: 134.23 (+1.89), LMNX: 15.45 (+0.02)
Techne Q2 Earnings, Revenues Miss Estimates but Grow Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 04, 8:56AM CST
Techne Corp. (TECH) reported adjusted earnings (EPS) of 82 cents per share in the second quarter of fiscal 2015, which missed the Zacks Consensus Estimate by 4 cents
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), TECH: 94.61 (+1.83), SURG: 4.44 (-0.02)
Pacific Biosciences Posts Q4 Loss as Expected, Shares Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 04, 8:28AM CST
Pacific Biosciences of California Inc. (PACB) plunged 5.2% (43 cents) to $7.90 in after-hours trading on the heels of disappointing fourth-quarter results.
ABMD: 60.39 (+0.46), PACB: 6.96 (-0.06), INGN: 33.53 (+2.32), SURG: 4.44 (-0.02)
InsiderInsights.com Daily Round Up 2/3/15: HES, FANG, ARDX, BH
InsiderInsights - at Seeking Alpha - Wed Feb 04, 5:43AM CST
NLSN: 45.59 (+2.02), HES: 76.83 (+2.12), CUBI: 22.29 (-0.14), FB: 75.74 (-0.49), LLY: 70.56 (+0.03), BMY: 60.04 (+0.56), ARDX: 17.14 (+0.71), ARCI: 2.53 (-0.01), BH: 416.41 (-1.55), WIW: 11.29 (unch), MJN: 101.89 (+2.32), SCTY: 57.60 (+0.44), ARRS: 26.68 (+0.41), GDOT: 15.54 (+0.34), INGN: 33.53 (+2.32), EMC: 27.99 (+0.12), FANG: 73.46 (+0.49), MSFT: 43.87 (+0.78), LENS: 6.00 (-0.67), BLMN: 24.45 (-0.16)
Intuitive Surgical Announces $1B Share Buyback Program - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 03, 4:57PM CST
Intuitive Surgical Inc (ISRG) recently announced a new share buyback program worth $1 billion.
ISRG: 510.73 (+3.02), ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), SURG: 4.44 (-0.02)
Wright Medical (WMGI) Gets Second Request from FTC - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 03, 3:20PM CST
Wright Medical Group, Inc. (WMGI) recently announced that it has received a Request for Additional Information and Documentary Material (commonly known as a Second Request) from the Federal Trade Commission ("FTC"
. WMGI: 25.68 (+0.17), INGN: 33.53 (+2.32), TRNX: 25.32 (+0.12), SURG: 4.44 (-0.02)
